Literature DB >> 16126125

Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.

Mohsen Janghorbani1, Masoud Amini.   

Abstract

BACKGROUND: Evidence on the long-term incidence of and risk factors of hypertension in diabetic patients is scarce and mainly derived from studies in developed countries. Evidence from developing countries is required for planning a well-co-ordinated approach to this public health problem in these countries.
OBJECTIVE: The objectives of present study were to estimate the incidence of and risk factors for the development of hypertension in people with type 2 diabetes mellitus using routinely collected data from a clinical information system at Isfahan Endocrinology and Metabolism Research Centre, Iran.
METHOD: During the mean (standard deviation (S.D.)) follow-up period of 2.9 (2.5) (range 1-11) years, 3202 diabetic patients (1315 male and 1887 female) from Isfahan Endocrinology and Metabolism Research Centre out patient clinics, Iran have been examined. The mean (S.D.) age of participants was 48.3 (10.6) years with a mean (S.D.) duration of diabetes of 6.5 (6.7) years at initial registration. Blood pressure was measured by standardised protocols, and hypertension was defined as at least in two consecutive measurements within 2 months a systolic and/or diastolic blood pressure of >or=130 and/or >or=80 mmHg and/or taking anti-hypertensive medication.
RESULTS: Among the 3202 patients free of hypertension at initial registration who attended the clinic at least twice in the period 1992-2004, the incidence of hypertension was 20.8 (20.6 male and 20.9 female) per 100 person-years based on 9403 person-years of follow-up. The age-adjusted incidence rate of hypertension was 22% lower among insulin-treated than non-insulin-treated type 2 diabetes mellitus clinic attenders and it was greater with older age. Using a Cox's Proportional Hazards Model, male gender, and treatment regimen were significant independent predictors of hypertension. Smoking, duration of diabetes, age at diagnosis of diabetes, fasting blood glucose, glycosylated haemoglobin, BMI, proteinuria and creatinine, had no significant independent association with hypertension when other covariates were considered.
CONCLUSION: These findings will help the identification of those patients at particular risk of hypertension and strongly support the case for vigorous control of blood pressure on type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126125     DOI: 10.1016/j.diabres.2005.02.017

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  11 in total

1.  Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitus.

Authors:  Karine Sahakyan; Barbara E K Klein; Chelsea E Myers; Michael Y Tsai; Ronald Klein
Journal:  Am Heart J       Date:  2010-06       Impact factor: 4.749

2.  Serum cystatin C and the incidence of hypertension in type 1 diabetes mellitus.

Authors:  Karine Sahakyan; Barbara E K Klein; Kristine E Lee; Michael Y Tsai; Ronald Klein
Journal:  Am J Hypertens       Date:  2010-09-30       Impact factor: 2.689

3.  Prevalence of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Iran: A Systematic Review and Meta-Analysis.

Authors:  Mohsen Kazeminia; Nader Salari; Masoud Mohammadi
Journal:  J Diabetes Res       Date:  2020-09-25       Impact factor: 4.011

4.  The association between glycosylated haemoglobin and newly diagnosed hypertension in a non-diabetic Sudanese population: a cross-sectional study.

Authors:  Saeed M Omar; Imad R Musa; Omer Abdelbagi; Manal E Sharif; Ishag Adam
Journal:  BMC Cardiovasc Disord       Date:  2022-05-10       Impact factor: 2.174

5.  Evidence Gap on the Prevalence of Non-conventional Risk Factors for Type 2 Diabetes in Iran.

Authors:  Abdolreza Shaghaghi; Ali Ahmadi
Journal:  Osong Public Health Res Perspect       Date:  2014-09-06

6.  The Prevalence of Metabolic Syndrome in Coronary Artery Disease Patients.

Authors:  Farzaneh Montazerifar; Ahmad Bolouri; Milad Mahmoudi Mozaffar; Mansour Karajibani
Journal:  Cardiol Res       Date:  2016-12-31

7.  Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study.

Authors:  Moluk Hadi Alijanvand; Ashraf Aminorroaya; Iraj Kazemi; Sima Aminorroaya Yamini; Mohsen Janghorbani; Masoud Amini; Marjan Mansourian
Journal:  Diabetes Metab Syndr Obes       Date:  2019-07-15       Impact factor: 3.168

8.  Plasma endothelial microparticles and their correlation with the presence of hypertension and arterial stiffness in patients with type 2 diabetes.

Authors:  Yinghua Chen; Bo Feng; Xu Li; Yafang Ni; Yun Luo
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-04-24       Impact factor: 3.738

9.  Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study.

Authors:  Roqayeh Aliyari; Ebrahim Hajizadeh; Ashraf Aminorroaya; Farshad Sharifi; Iraj Kazemi; Ahmad-Reza Baghestani
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-28       Impact factor: 3.168

Review 10.  Coronary artery disease and its risk factors status in iran: a review.

Authors:  M Ebrahimi; S M R Kazemi-Bajestani; M Ghayour-Mobarhan; G A A Ferns
Journal:  Iran Red Crescent Med J       Date:  2011-09-15       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.